These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3476195)
1. Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562. Tonini GP; Radzioch D; Gronberg A; Clayton M; Blasi E; Benetton G; Varesio L Cancer Res; 1987 Sep; 47(17):4544-7. PubMed ID: 3476195 [TBL] [Abstract][Full Text] [Related]
2. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis. Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329 [TBL] [Abstract][Full Text] [Related]
3. Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II). Marazzi L; Parodi MT; Di Martino D; Ferrari S; Tonini GP Anticancer Res; 1991; 11(2):947-52. PubMed ID: 2064352 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Delgado MD; Lerga A; Cañelles M; Gómez-Casares MT; León J Oncogene; 1995 Apr; 10(8):1659-65. PubMed ID: 7731722 [TBL] [Abstract][Full Text] [Related]
5. Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease. Bianchi Scarrà GL; Romani M; Coviello DA; Garrè C; Ravazzolo R; Vidali G; Ajmar F Cancer Res; 1986 Dec; 46(12 Pt 1):6327-32. PubMed ID: 3536078 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of interaction between antineoplastic agents and natural differentiation factors in the induction of human leukemic cell maturation. Honma Y; Honma C; Bloch A Cancer Res; 1986 Dec; 46(12 Pt 1):6311-5. PubMed ID: 3465437 [TBL] [Abstract][Full Text] [Related]
7. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine. Okabe-Kado J; Hayashi M; Honma Y; Hozumi M Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882 [TBL] [Abstract][Full Text] [Related]
8. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase. Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells. Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of c-myc gene is not obligatory for growth inhibition and differentiation of human myeloid leukemia cells. Gómez-Casares MT; Delgado MD; Lerga A; Crespo P; Quincoces AF; Richard C; León J Leukemia; 1993 Nov; 7(11):1824-33. PubMed ID: 8231250 [TBL] [Abstract][Full Text] [Related]
11. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation. Kirsch IR; Bertness V; Silver J; Hollis GF J Cell Biochem; 1986; 32(1):11-21. PubMed ID: 3464612 [TBL] [Abstract][Full Text] [Related]
12. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation. Marks PA; Ramsay R; Sheffery M; Rifkind RA Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077 [TBL] [Abstract][Full Text] [Related]
13. Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives. Szulawska A; Arkusinska J; Czyz M Biochem Pharmacol; 2007 Jan; 73(2):175-84. PubMed ID: 17097070 [TBL] [Abstract][Full Text] [Related]
14. Effects of chebulinic acid on differentiation of human leukemia K562 cells. Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215 [TBL] [Abstract][Full Text] [Related]
15. Inhibition by 1,25 dihydroxyvitamin D3 of c-myc down-regulation and DNA fragmentation in cytosine arabinoside-induced erythroid differentiation of K562 cells. Moore DC; Carter DL; Studzinski GP J Cell Physiol; 1992 Jun; 151(3):539-48. PubMed ID: 1295901 [TBL] [Abstract][Full Text] [Related]
16. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade. Liebermann DA; Hoffman-Liebermann B Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131 [TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888 [TBL] [Abstract][Full Text] [Related]
18. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation. Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254 [TBL] [Abstract][Full Text] [Related]
19. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells. Watanabe T; Mitchell T; Sariban E; Sabbath K; Griffin J; Kufe D Mol Pharmacol; 1985 Jun; 27(6):683-8. PubMed ID: 3858662 [TBL] [Abstract][Full Text] [Related]
20. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells. Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]